Table of Contents
A prior art search Milan litigation counsel can rely on has to reflect where Italy’s patent fights are actually decided — and today that is Milan itself. The city is Italy’s leading patent venue: the Tribunale di Milano’s specialised business division (sezione specializzata in materia di impresa) hears more patent cases than any other Italian court. Since 27 June 2024 Milan also hosts the third seat of the Unified Patent Court’s Central Division, giving the city a cross-border revocation forum on top of its national one. With fashion, design, pharmaceuticals, life sciences, machinery and finance all concentrated in Lombardy, PerspireIP builds invalidity-grade searches for the accused parties and counsel fighting those patents across the Italian courts, the EPO and the UPC.
Where a prior art search Milan case is actually heard
Italy channels patent disputes into a handful of specialised business divisions — the sezioni specializzate in materia di impresa, often called the tribunale delle imprese — and Milan is the busiest of them. The Tribunale di Milano’s specialised division handles more patent infringement and nullity actions than Turin or Rome, and its judges are experienced across pharmaceutical, mechanical, electronics and standard-essential patent disputes. Appeals go to the specialised industrial-property section of the Milan Court of Appeal (Corte d’Appello di Milano).
That concentration makes the prior art decisive. In an Italian nullity action the accused party asks the court to revoke the patent for lack of novelty or inventive step, and the result turns on what was publicly available before the priority date. Whether the fight is a defensive counterclaim to an infringement suit or a standalone nullity action, the invalidity search is the engine of the case.
- Tribunale di Milano, sezione specializzata in materia di impresa — Italy’s leading first-instance patent court for infringement and nullity
- Corte d’Appello di Milano — specialised industrial-property section hearing patent appeals
- EPO Opposition Division — central attack on a European patent within nine months of grant
- Unified Patent Court — revocation of unitary and non-opted-out European patents, with a Central Division seat now in Milan
The UPC Milan Central Division and exactly what it hears
On 27 June 2024 Milan opened the third seat of the Unified Patent Court’s Central Division, joining Paris and Munich. Housed in the Court of Milan complex on Via San Barnaba, the Milan section took over the workload that had been earmarked for London before the United Kingdom withdrew from the UPC after Brexit. Italy is a full UPC and EPC member state, so the seat gives litigants a pan-European revocation forum on Italian soil.
Its competence is defined by subject-matter, not geography. The Milan section hears validity disputes in WIPO IPC Section A — “human necessities” — which covers pharmaceuticals, medical devices, agro-chemistry and phytosanitary products, food and tobacco, home appliances, furniture, fashion, sport and entertainment. One carve-out matters: supplementary protection certificates (SPCs) stay with the Paris seat, so an SPC-based dispute is not a Milan Central Division case even when the underlying drug patent is.
That allocation shapes how a prior art search Milan counsel commissions should be scoped. If the asserted patent sits in IPC Section A, a UPC revocation action or counterclaim may run in Milan itself — and the same claim-by-claim invalidity evidence that supports a national nullity action can feed it.
Italian nullity, EPO opposition or UPC revocation: three routes
An accused party in Milan usually has more than one way to attack a patent, and the routes are not interchangeable. An Italian nullity action before the Milan specialised division revokes only the Italian designation and is decided under Italian and EPC standards of novelty and inventive step. EPO opposition is a central attack: filed within nine months of grant, it can knock out the European patent in every designated state at once.
The Unified Patent Court adds a third route. A UPC revocation action — or a revocation counterclaim raised in an infringement case — can kill a unitary patent, or a European patent that has not been opted out, across all participating states in a single judgment. For IPC Section A subject-matter the standalone revocation action is heard in the Milan Central Division; SPC validity remains in Paris and chemistry outside Section A sits with Munich.
The routes share one dependency: prior art. One rigorous invalidity search, charted claim by claim, can feed an Italian nullity action, a nine-month EPO opposition and a UPC revocation at the same time — so the same evidence works whichever forum you choose, or across several at once.
Milan’s industries and where its patent fights come from
Milan is Italy’s economic and industrial capital, and its patent litigation mirrors the local economy. Lombardy is the heart of Italian pharma and life sciences, with major manufacturers and contract producers across the region, which is exactly the human-necessities subject-matter the UPC Milan section was built to hear. Small-molecule formulations, biologics, medical devices and diagnostic methods are recurring themes.
Beyond pharma, Milan is a global fashion and design hub — home to the fashion weeks, the Salone del Mobile furniture fair and a dense base of textile, apparel, footwear and furniture makers. It is also a machinery and industrial-automation centre and Italy’s financial capital. Each field generates its own patent disputes: mechanical and process claims from machinery, formulation and device claims from pharma and medtech, and functional and design-adjacent claims from fashion and furniture.
Where fashion, design, pharma and machinery prior art lives
Different fields hide their decisive prior art in different places, and an invalidity search has to reach the right literature for each. For pharma, life-science and chemistry claims a great deal of the anticipating art never appears in a patent database at all — it lives in the journal record and in specialist compound and sequence collections. A credible invalidity search there must search those sources directly and prove the public-availability date of each reference.
- Chemical Abstracts (CAS), peer-reviewed journals, and sequence and structure databases for pharma, biologics and formulation claims
- Machinery and automation catalogues, standards, technical manuals and older patent families for mechanical and process claims
- Trade-fair catalogues, look-books, dated product releases and design registers for fashion and furniture claims — where a public disclosure at a Milan fair can itself be the anticipating reference
- Conference abstracts, theses and dated technical disclosures across every field, each argued as novelty or inventive-step art
For a fashion or furniture claim the anticipating reference is often a prior showing at a trade fair or an older catalogue; for a pharma claim it is frequently an older paper or an abandoned patent family. We treat dating as evidence to be proved — establishing that each reference was genuinely public before the priority date the claim actually relies on.
Cross-border Italian and European patent families
A Milan dispute is rarely confined to Italy. Most patents asserted here are European patents (granted by the EPO) validated in several states, or unitary patents covering the whole UPC area, so the same family is often enforced in parallel in Germany, France and beyond. A patent asserted before the Milan specialised division may have siblings enforced through the UPC’s local divisions or the German national courts at the same time.
That cross-border reality changes how a prior art search Milan counsel commissions should be scoped. The art has to be robust across jurisdictions and languages — Italian, English, German and French — because a reference that anticipates a claim in Milan should also carry weight in an EPO opposition or a parallel UPC or German proceeding. We build searches that travel, so one evidence set supports a coordinated defence rather than a patchwork of separate ones.
How PerspireIP builds a prior art search Milan case can rely on
Every engagement follows the same disciplined path. We map the asserted claims element by element, fix the priority date that actually governs each one, and search against that date rather than the filing date on the cover. For pharma and life-science subject-matter we run patent and deep non-patent-literature searching in parallel; for machinery, fashion and design we add catalogues, standards, trade-fair records and design registers — then build claim charts a Milan judge, an EPO Opposition Division or a UPC panel can follow.
- Claim charting mapped to novelty and inventive step under the EPC and Italian law
- Deep retrieval across CAS, peer-reviewed journals, sequence databases, industrial catalogues, standards and older patent families
- Public-availability dating for every reference, evidenced in Italian, English, German and French
- Prior art sized to your forum — an Italian nullity action, the nine-month EPO opposition window, or UPC revocation before the Milan Central Division
- A written invalidity analysis and reference packages ready for court, the EPO or the UPC
We work alongside your Italian and European counsel as a specialist search partner, deliver to Milan, EPO and UPC deadlines, and keep every engagement confidential. Whether you are a Lombardy manufacturer facing an assertion, a generics or biosimilar entrant clearing a path, or litigation counsel preparing a cross-border defence, we scale to fit — a single search, a multi-patent campaign or ongoing support. Send us the patent number and your key dates, and we will scope a prior art search Milan project within one business day.
IP Landscape & Resources in Milan
Key intellectual-property authorities and venues relevant to Milan:
- UIBM (Ufficio Italiano Brevetti e Marchi) — the Italian Patent and Trademark Office, which grants Italian patents and trademarks
- Tribunale di Milano — Tribunale delle Imprese — the Milan specialised business division, Italy's leading first-instance patent court for infringement and nullity
- Unified Patent Court (UPC) — hears revocation of unitary and non-opted-out European patents; its third Central Division seat opened in Milan on 27 June 2024
- European Patent Office (EPO) — grants European patents and runs post-grant opposition, a central attack filed within nine months of grant
Request a Prior Art Search in Milan
Request a Prior Art Search in Milan
Get an invalidity-grade prior-art search built for an Italian nullity action, a nine-month EPO opposition, or UPC revocation before the Milan Central Division, tuned for pharma, machinery, fashion and design claims. Send us the patent number and your key dates, and we will scope the work within one business day.
Explore related PerspireIP services: Prior Art Litigation Search · Patent Invalidation · Patent Infringement Analysis.
Frequently Asked Questions
Where is a Milan patent case litigated?
At first instance, before the Tribunale di Milano’s specialised business division (sezione specializzata in materia di impresa), which handles more patent infringement and nullity actions than any other Italian court, with appeals to the specialised industrial-property section of the Milan Court of Appeal. Since 27 June 2024 Milan also hosts the third seat of the Unified Patent Court’s Central Division, so for European and unitary patents litigants can also choose the UPC. Which forum fits depends on whether you want national scope or a pan-European judgment.
What does the UPC Milan Central Division actually hear?
The Milan section of the UPC Central Division, open since 27 June 2024, hears validity disputes in WIPO IPC Section A — “human necessities” — covering pharmaceuticals, medical devices, agro-chemistry, food, tobacco, home appliances, furniture, fashion and sport. It took over the caseload originally planned for London after Brexit. One key exclusion applies: supplementary protection certificates (SPCs) stay with the Paris seat, so an SPC-based validity dispute is not a Milan Central Division case even when the underlying patent is.
Italian nullity, EPO opposition or UPC revocation — which route invalidates the patent?
They do different things. An Italian nullity action before the Milan specialised division revokes only the Italian designation. EPO opposition, filed within nine months of grant, is a central attack that can revoke the European patent in all designated states at once. UPC revocation kills a unitary patent, or a non-opted-out European patent, across participating states in one judgment — and for IPC Section A subject-matter that action is heard in the Milan Central Division. One prior art search can feed all three.
Does fashion and design prior art differ from pharma prior art?
Yes, and the search has to change with the field. For pharma, life-science and chemistry claims the decisive art often sits outside patent databases — in the journal literature indexed by Chemical Abstracts (CAS) and in sequence and structure databases. For fashion and furniture claims the anticipating reference is frequently a prior public showing at a Milan trade fair, an older catalogue or a design register, while machinery claims turn on catalogues, standards and older patent families. We search the right sources for each and prove every reference was public before the priority date.